“Lunar-Cov19” is one of 25 international candidate vaccines to succeed in the human test level and will be tested on 108 healthy volunteers of other ages in Singapore, the newspaper said.
The trial will be protected by the vaccine and its ability to produce the “soldiers” needed to help fight the infection, said Professor Ooi Eng Eong, deputy director of the Emerging Infectious Diseases Program at Duke-NUS School of Medicine.
Click here to read Mint ePaperLivemint.com is now on Telegram. Join the Livemint channel on your telegram and updated
Log in to our to save your favorites. It’ll only take a moment.
Your query has expired, reconnect.
You are now subscribed to our newsletters. If you can’t find any email from us, check your spam folder.